...
首页> 外文期刊>The joint commission journal on quality and patient safety >Development and Implementation of a Subcutaneous Insulin Pen Label Bar Code Scanning Protocol to Prevent Wrong-Patient Insulin Pen Errors
【24h】

Development and Implementation of a Subcutaneous Insulin Pen Label Bar Code Scanning Protocol to Prevent Wrong-Patient Insulin Pen Errors

机译:皮下胰岛素笔标签条码扫描协议的开发和实施,以防止错误患者胰岛素笔错误

获取原文
获取原文并翻译 | 示例
           

摘要

Problem Definition: Insulin, a high-alert medication, is regularly prescribed in the inpatient setting for hyperglycemiaand diabetes mellitus. Although convenient, insulin pens carry a risk of blood-borne pathogens if the same pen is used on multiplepatients. At the University of California, San Francisco (UCSF), a new nursing protocol for insulin pen administrationwas developed to ensure that insulin was quickly available and to identify and move to eliminate wrong-patient insulin penerrors. This protocol involved unit-based automated dispensing machines and an electronic health record (EHR)–integratedpatient-specific bar code label work flow.Approach: After piloting on three hospital units, this new patient-specific bar code label process was expanded hospitalwide.“Print Label For Insulin Pen”and “Scan Insulin Pen”buttons were programmed into the EHR to enable nurses toprint patient-specific bar code labels. In addition, a “wrong-patient pen alert”was activated to prevent wrong-pen insulinpen administration.Outcomes: For the 162,075 inpatient insulin pen administrations during the study period (April 2017–March 2018),monthly errors (rates) ranged from 13 (0.12%) to 36 (0.23%). In total, 296 near-miss events (0.18% of all insulin penadministrations) were observed and prevented.Conclusion: Insulin pen work flow and EHR changes implemented at UCSF enable subcutaneous insulin to remain atime-critical medication and ensure patient safety. The wide adoption of EHRs offers an opportunity to integrate patientsafety improvements directly into the electronic medication administration record systems to maximize patient safety.
机译:问题定义:胰岛素,一种高警报药物,在高血糖血症的住院环境中定期规定和糖尿病。虽然方便,胰岛素钢笔如果在多个中使用相同的笔,胰岛素笔患有血型病原体的风险耐心。在加利福尼亚大学,旧金山(UCSF),胰岛素笔管理的新护理议定书是开发的,以确保胰岛素快速可用并识别和移动以消除错误的患者胰岛素笔错误。该协议涉及基于单位的自动分配机和电子健康记录(EHR) - 集成特定患者的条形码标签工作流程。方法:在三个医院单位驾驶后,这个新的患者特定的条形码标签进程在Headywide中扩展。“胰岛素笔的印刷标签”和“扫描胰岛素笔”按钮被编程到EHR中以使护士能够实现打印特定于患者的条形码标签。此外,激活了“错误患者笔警报”以防止错误的笔胰岛素笔管理。结果:在研究期间的162,075个入住胰岛素笔施用(2017年4月至2018年3月),每月误差(速率)从13(0.12%)到36(0.23%)。总共,296次近小姐的事件(所有胰岛素笔的0.18%观察和预防署长)。结论:UCSF实施的胰岛素笔工作流程和EHR变化使皮下胰岛素仍然存在时间关键药物,确保患者安全。广泛采用的EHRS提供了整合病人的机会安全改进直接进入电子药物管理记录系统,以最大限度地提高患者安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号